Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

264 results about "Rhinitis allergic" patented technology

Allergic rhinitis is a diagnosis associated with a group of symptoms affecting the nose. These symptoms occur when you breathe in something you are allergic to, such as dust, animal dander, or pollen.

Lactobacillus paracasei BN07 for relieving allergic rhinitis and allergic dermatitis and application of lactobacillus paracasei BN07

PendingCN119020192AAlleviate allergic inflammationRelieve allergic rhinitisBacteriaAntipyreticBiotechnologyAllergic dermatitis
The invention discloses a Lactobacillus paracasei BN07 for relieving allergic rhinitis and allergic dermatitis and application of the Lactobacillus paracasei BN07. The Lactobacillus paracasei BN07 is preserved in the General Microbiological Center of China Committee for Culture Collection of Microorganisms on November 22, 2023, and the preservation number is CGMCC No.29104. The Lactobacillus paracasei BN07 is preserved in the General Microbiological Center of China Committee for Culture Collection of Microorganisms on November 22, 2023. The lactobacillus paracasei BN07 not only can relieve allergic rhinitis, but also can relieve allergic dermatitis, and is remarkable in effect, healthy and safe.
Owner:湖南益百益优生物科技有限公司

Nasal gel for treating allergic rhinitis and preparation method thereof

The invention discloses a nasal gel for treating allergic rhinitis and a preparation method thereof, and relates to the technical field of medicines. The nasal gel for treating allergic rhinitis is prepared from double-sensitive double-network drug-loaded gel microspheres and a temperature-sensitive gel material, the double-sensitive double-network drug-loaded gel microspheres are prepared from sodium alginate, a temperature-sensitive polymer, lactoferrin, a traditional Chinese medicine extracting solution and calcium chloride, the temperature-sensitive gel material is prepared from silk fibroin, carboxymethyl chitosan, K-carrageenan and genipin; the double-sensitive double-network drug-loading gel microspheres are loaded in the temperature-sensitive gel material, and after the temperature-sensitive gel material enters the nasal cavity, the temperature-sensitive gel material is quickly converted into gel to be adhered to nasal cilia, so that the removal of the double-sensitive double-network drug-loading gel microspheres by the motion of the nasal cilia is reduced, and the gel microspheres can better release a double-layer drug-loading system; the acting time of the medicine in the nasal cavity is prolonged, the bioavailability of the medicine is improved, the allergic rhinitis is effectively treated, and uncomfortable symptoms are relieved.
Owner:BEIJING CIMINGTANG MEDICAL RES INST

Bifidobacterium animalis and application thereof in allergic rhinitis products

The invention discloses bifidobacterium animalis and application thereof in allergic rhinitis products, and belongs to the technical field of microorganisms. The technical problem to be solved is that the existing common allergic rhinitis treatment means cannot meet the requirements of patients on safety, long-acting effect and treatment cycle. The invention provides an animal bifidobacterium subsp. Lactis Def +, and after an effective dose of animal bifidobacterium subsp. Lactis Def + is applied to a subject, the animal bifidobacterium subsp. Lactis Def + is found to be capable of remarkably relieving the allergic rhinitis symptom. Specifically, the symptoms of sneezing, dry nose and rhinocnesmus are reduced; the number of nasal septum mucosa intrinsic layer inflammation infiltration cells and nasal septum mucosa epithelium pathological changes are reduced; the IgA and IgE levels of serum are reduced; the levels of proinflammatory factors IL-4, IL-5 and IL-13 are reduced; the normal spleen index is maintained; the imbalance state of Th1 / Th2 and Th17 / Treg is effectively improved, and the body immunity is improved; a safe and long-acting scheme is provided for allergic rhinitis diseases.
Owner:ZHONGKE WISBIOM(BEIJING)BIOTECHNOLOGY CO LTD

Anti-allergy agent containing compound plant anti-allergy active ingredients as well as preparation method and application of anti-allergy agent

The invention is suitable for the technical field of anti-allergy agents, and provides an anti-allergy agent containing compound plant anti-allergy active ingredients. Comprising 5-10 parts of a bletilla striata extract, 8-15 parts of an aloe extract, 7-12 parts of an angelica sinensis extract, 10-20 parts of a centella asiatica extract, 5-15 parts of a rosemary extract, 8-18 parts of a polygonum cuspidatum extract, 12-25 parts of a scutellaria baicalensis extract, 3-10 parts of a tea extract, 6-15 parts of a liquorice extract and 4-12 parts of a matricaria recutita extract. The preparation method of the anti-allergy agent containing the compound plant anti-allergy active ingredients comprises the following steps: step 1, extracting and concentrating in groups; step 2, compounding additional ingredients; and step 3, mixing and forming the preparation. The anti-allergy agent containing the compound plant anti-allergy active component is specifically applied to allergic rhinitis nasal spray, postoperative wound repair, pet skin anti-allergy spray, anti-allergy baby clothes treating agent, low-allergy household cleaning agent and air purification spray. And through the synergistic effect of multiple targets and multiple channels, the balanced synergism of the repairing effect and the relieving effect is realized.
Owner:HUZHOU JIAMEI BIOCHEM PRODS

Application of lactobacillus rhamnosus in preparation of preparation for relieving allergic rhinitis

The invention discloses application of lactobacillus rhamnosus in preparation of a preparation for relieving allergic rhinitis. The invention provides application of the lactobacillus rhamnosus OF44-15Ph10T or a composition containing the lactobacillus rhamnosus OF44-15Ph10T in preparation of a product with at least one of the following functions: preventing and / or treating allergic rhinitis; the symptoms of allergic rhinitis are improved or relieved; the nasal mucosa injury caused by allergic rhinitis is repaired; intestinal pathogens are inhibited; the intestinal flora balance is regulated; the lactobacillus rhamnosus OF44-15Ph10T provided by the invention provides a new direction for treating allergic rhinitis, can be applied to the fields of food, health care products and medicines, and has a wide industrial prospect.
Owner:BGI PRECISION NUTRITION (SHENZHEN) TECHNOLOGY CO LTD

Application of FGL1 protein in preparation of kit for diagnosing allergic rhinitis

PendingCN119804873ABiological testingFGL1Healthy subjects
The invention discloses application of FGL1 protein in preparation of a kit for diagnosing allergic rhinitis. It is found that the FGL1 protein content in the serum of a healthy subject and the FGL1 protein content in the serum of an allergic rhinitis patient are obviously different, and the FGL1 protein content in the serum of the allergic rhinitis patient is obviously higher than that of the healthy subject. A further diagnosis efficacy test shows that the FGL1 protein can effectively diagnose and distinguish healthy subjects and allergic rhinitis patients, the diagnosis accuracy is high, the FGL1 protein can be used for developing a kit for diagnosing allergic rhinitis, and the objectivity is obviously improved compared with an existing diagnosis method.
Owner:JIANGSU PRECISE MEDICAL TECH CO LTD

Application of bifidobacterium animalis subsp. Lactis in preparation of preparation for preventing and / or treating allergic rhinitis

The invention relates to application of bifidobacterium animalis subsp. Lactis in preparation of a preparation for preventing and / or treating allergic rhinitis. The bifidobacterium animalis subsp. Lactis comprises Bifidobacterium animalis subsp. Lactis BGI-N3, the Bifidobacterium animalis subsp. Lactis BGI-N3 is preserved in the China Center for Type Culture Collection on October 17, 2022, and the preservation number of the Bifidobacterium animalis subsp. Lactis BGI-N3 is CCTCC (China Center for Type Culture Collection) NO: M20221585. Based on an allergic rhinitis animal model, the action mechanism of the animal bifidobacterium subsp. Lactis in the inflammation process is deeply analyzed, it is found that the animal bifidobacterium subsp. Lactis can effectively prevent and / or treat allergic rhinitis, and a new strategy is provided for developing a scheme for treating allergic rhinitis.
Owner:BGI PRECISION NUTRITION (SHENZHEN) TECHNOLOGY CO LTD

Biological combined preparation for allergic rhinitis and preparation method thereof

The invention provides a biological combined preparation for allergic rhinitis and a preparation method of the biological combined preparation. The preparation comprises antibacterial polysaccharide, a centipeda minima extract, anti-allergic probiotics, an active polypeptide compound, sodium hyaluronate, an immunomodulator, a penetration enhancer, a biological adhesive and the like. Wherein the antibacterial polysaccharide can be selected from various natural polysaccharides; the centipeda minima extract is obtained by a specific ethanol reflux method; the antiallergic probiotics comprise lactobacillus acidophilus, lactobacillus rhamnosus and lactobacillus reuteri; the active polypeptide compound consists of thymosin, glutathione and osteogenic peptide. The preparation method comprises the following steps: sequentially mixing the components, carrying out high-pressure homogenization treatment, carrying out ultrasonic treatment, adding probiotics, stirring, intercepting with an ultrafiltration membrane, freeze-drying and the like. The preparation disclosed by the invention can form a uniform nano-scale particle suspension, so that the release rate and the absorption efficiency of the medicine are further improved, and an efficient, safe and convenient novel method is provided for treating the allergic rhinitis.
Owner:GUANGZHOU GREENWALL BIOMEDICAL TECH CO LTD

Oral composition for treating allergic rhinitis

The invention relates to a pharmaceutical composition, in particular to an oral composition for treating allergic rhinitis, which takes magnolia flower and baical skullcap root as monarch drugs, dahurian angelica root, divaricate saposhnikovia root, szechuan lovage rhizome, milkvetch root and Indian buead as ministerial drugs, liquoric root as a guide and the balance as adjuvant drugs. Comprising the following components: 2-3 parts of biond magnolia flower, 2-3 parts of angelica dahurica, 3-5 parts of fructus forsythiae, 3-5 parts of fried burdock, 2-3 parts of divaricate saposhnikovia root, 3-5 parts of dandelion, 3-5 parts of astragalus membranaceus, 3-5 parts of scutellaria baicalensis, 3-5 parts of poria cocos, 3-5 parts of bighead atractylodes rhizome, 10-15 parts of coix seed, 2-3 parts of ligusticum wallichii, 2-3 parts of radix scrophulariae The traditional Chinese medicine preparation for treating wind-heat invading lung and spleen qi weakness type allergic rhinitis has the effects of dispelling wind, clearing lung, dredging nasal orifices and replenishing qi to invigorate the spleen, the symptoms of patients are relieved, and the living quality of vast child patients is improved.
Owner:SHANGHAI CHILDRENS MEDICAL CENT AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE

Composite probiotic composition for improving allergic rhinitis as well as preparation method and application of composite probiotic composition

The invention provides a compound probiotic composition for improving allergic rhinitis as well as a preparation method and application thereof, and belongs to the technical field of biological preparations. Comprising a composite probiotic liquid, an auxiliary agent, a humectant and a thickening agent, wherein the composite probiotic liquid is composed of a composite bacterium fermentation liquid and probiotic substances, and the composite fermentation liquid is prepared by respectively fermenting saccharomyces boulardii, two bifidobacteria, lactobacillus reuteri, lactobacillus rhamnosus and streptococcus thermophilus. According to the compound probiotic composition, growth of probiotics is promoted through different probiotics, flora balance is adjusted and immunity is improved through mutual cooperation of the different probiotics, rhinitis symptoms are improved, meanwhile, components such as centipeda minima are added to serve as auxiliaries, and the effect of improving rhinitis symptoms is achieved. And the probiotics and the compound probiotics can achieve a synergistic effect to jointly improve the symptoms of the allergic rhinitis.
Owner:胡永刚

A Chinese medicine composition for treating allergic rhinitis and its preparation method and application

ActiveCN118384202Breduce usageAlleviate allergy symptomsOrganic active ingredientsAntipyreticIncreased inflammatory responseT cell
The present invention proposes a Chinese medicine composition for treating allergic rhinitis, and a preparation method and application thereof, which belong to the field of pharmaceutical technology. Ag-graphene oxide is adsorbed on in vitro proliferated γδT cells, a Chinese medicine fermentation product obtained by fermentation and extraction of Xanthium sibiricum, Astragalus, Poria, Magnolia officinalis, and Mentha is prepared, berberine and quercetin are prepared into eutectic powder, the three are mixed and added into water, probiotics, carboxymethyl chitosan, poloxamer 407 and poloxamer 188 are added, and mixed evenly to prepare a Chinese medicine composition for treating allergic rhinitis, which has a good effect of improving allergic rhinitis, adopts a method of combining traditional Chinese and Western medicine, reduces inflammatory response, enhances the immune function of patients, improves the clinical symptoms of patients with allergic rhinitis, reduces the long-term recurrence rate, reduces the use of drugs, improves the quality of life, and reduces the risk of developing asthma, and has broad application prospects.
Owner:BEI CHUANG KAIYUAN (BEIJING) PHARM TECH CO LTD

Physiotherapy moxibustion instrument for allergic rhinitis

InactiveCN119097549AMoxibustion uniformAvoid heat moxibustionDevices for heating/cooling reflex pointsMechanical engineeringGeneral surgery
The invention relates to the technical field of moxibustion instruments, in particular to a physical therapy moxibustion instrument for allergic rhinitis. Ear parts are arranged on the two sides of the eyeshade, a supporting rod is rotationally arranged on the inner wall of a protection shell, a half gear is arranged in the center of the supporting rod, symmetrical meshing gears are arranged at the two ends of the supporting rod, and a rotating assembly is arranged at the end of an auxiliary plate and used for driving a base plate to rotate, so that moxa cones fixed to the ends of fixing needles conduct moxibustion on acupuncture points. The output end of the motor drives the transmission shaft sleeve to rotate through the transmission belt, at the moment, the base plate and the transmission shaft sleeve coaxially rotate, the fixing needle at the end of the base plate drives the moxa cone to rotate, and due to the fact that the end of the fixing needle is in a bent shape, when the fixing needle drives the moxa cone to rotate, the moxa cone is fixed to the base plate. The moxa cone performs uniform moxibustion on the periphery of an acupuncture point needing to be treated, and the moxa cone is prevented from being always located at a fixed position to perform heating moxibustion on the acupuncture point, so that the skin of a patient is protected from being scalded.
Owner:BEIJING UNIV OF CHINESE MEDICINE

Allergic rhinitis diagnosis and allergen tracing system based on dynamic text guidance

The invention discloses an allergic rhinitis diagnosis and allergen traceability system based on dynamic text guidance, and belongs to the technical field of intelligent medical treatment. According to the method, the problems that in the prior art, patient description is inaccurate, allergens are various in variety and have differences, and allergens are difficult to accurately determine and trace are solved, the initial situational sub-graph is verified by introducing periodic features of the patient, the causal contribution degree of the initial situational sub-graph is evaluated through a Bayesian reasoning algorithm, and a mode association result library is formed; according to the method, the crossing of the allergic rhinitis diagnosis and tracing from the traditional static judgment to the dynamic accurate inference is realized, and a personalized and scientific allergen avoidance scheme is provided for patients; through similarity retrieval, environmental information injection verification and calculation of a mode goodness-of-fit score, under the condition that patient symptoms are in multi-factor mixing, a mixed causal graph is created through a graph fusion technology, and the mode goodness-of-fit score is calculated again, so that the accuracy of obtaining an allergen traceability result in practical application is ensured.
Owner:THE THIRD MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL

Method for preparing allergic rhinitis spray from umbilical cord mesenchymal stem cell exosome

The invention relates to the technical field of rhinitis spray preparation, in particular to a method for preparing allergic rhinitis spray from umbilical cord mesenchymal stem cell exosomes, which comprises the following steps: 1, umbilical cord treatment; 2, culturing umbilical cord mesenchymal stem cells; 3, preparing an umbilical cord mesenchymal stem cell exosome; and 4, preparing the rhinitis spray. The rhinitis spray prepared by the method disclosed by the invention is simpler and more convenient to use. The exosome, the platelet growth factor and other substances in the rhinitis spray well solve the core problems of single curative effect, large side effect, low compliance and the like in the traditional rhinitis treatment, and through the induction and repair functions of the stem cell exosome and the bactericidal ability of the antibacterial peptide, the nasal cavity environment is improved, the anaphylactic reaction is reduced, the nasal mucosa is repaired, and the rhinitis treatment effect is improved. The allergic rhinitis is expected to be fundamentally treated.
Owner:山西药科职业学院

Application of tea extracellular vesicles in preparation of medicine for relieving or treating allergic respiratory diseases

The invention provides application of tea extracellular vesicles in preparation of drugs for relieving or treating allergic respiratory diseases, and belongs to the technical field of extracellular vesicles. The invention provides application of tea extracellular vesicles in preparation of drugs for relieving or treating allergic respiratory diseases. The tea extracellular vesicles are proved to be capable of remarkably improving related symptoms of allergic respiratory diseases including allergic rhinitis, have good anti-inflammatory and immunoregulation effects, and have the application potential of being used as natural active ingredients for preparing drugs or nasal delivery preparations for treating the allergic respiratory diseases. Compared with existing hormone drugs, the tea extracellular vesicles have the advantages of being natural in source, high in safety, low in side effect and the like; moreover, the extracellular vesicles have nanoscale particle sizes, good mucous membrane permeability and bioavailability, can improve the curative effect, and are suitable for long-term intervention.
Owner:XIAMEN BIYAN BIOTECHNOLOGY CO LTD

Application of bifidobacterium longum in improving immunity and preparing product for preventing, treating and / or adjunctively treating rhinitis

The invention belongs to the technical field of microorganisms, and particularly relates to application of bifidobacterium longum in improving immunity and preparing products for preventing, treating and / or assisting in treating rhinitis. The preservation number of the bifidobacterium longum is GDMCC No: 65969, and the bifidobacterium longum can reduce the levels of MDA and NO in serum of mice and improve the activity of SOD and CAT and the content of GSH so as to relieve oxidative stress injury; inflammatory cell infiltration of nasal mucosa is reduced, and lung tissue inflammatory mediator level and inflammation-related gene expression are reduced to inhibit inflammation; th1 / Th2 immune balance is regulated, Th2 type cytokines are reduced, Th1 type cytokines are increased, and the high-dosage effect is close to that of loratadine. The strain has a treatment effect on allergic rhinitis through multiple mechanisms, and a new choice is provided for treatment of the strain.
Owner:THANKCOME BIOLOGICAL SCI & TECH CO LTD

Disease monitoring and diagnosing system for allergic rhinitis and asthma syndrome treated by traditional Chinese medicine

The invention belongs to the technical field of intelligent medical treatment, and discloses a disease monitoring and diagnosis system for allergic rhinitis and asthma syndromes treated by traditional Chinese medicines. Comprising the steps of collecting a health portrait of a patient and traditional Chinese medicine diagnosis information and performing comprehensive differentiation to obtain a traditional Chinese medicine differentiation result; analyzing the health portrait of the patient, identifying abnormal medical indexes, performing disease diagnosis based on the abnormal medical indexes, and evaluating corresponding comprehensive clinical characterization to form a western medicine diagnosis result; performing cross validation on the traditional Chinese medicine differentiation result and the western medicine diagnosis result to obtain a comprehensive diagnosis result, and dynamically generating a personalized traditional Chinese medicine prescription in combination with the obtained patient personalized factors; environment perception factors are dynamically obtained, and the personalized traditional Chinese medicine prescription is intelligently optimized; the system provides full-process intelligent support for traditional Chinese medicine diagnosis and treatment of the allergic rhinitis and asthma syndrome, so that the diagnosis and treatment quality and the treatment effect are effectively improved, and a more scientific and effective traditional Chinese medicine treatment scheme is provided for patients.
Owner:HUNAN ANXIANG ZHENGYANGHE NETWORK TECH CO LTD

Nasal temperature-sensitive hydrogel with immunoregulation and anti-inflammatory functions as well as preparation method and application of nasal temperature-sensitive hydrogel

The invention belongs to the technical field of biological medicines, and particularly relates to nasal temperature-sensitive hydrogel with immunoregulation and anti-inflammatory functions as well as a preparation method and application of the nasal temperature-sensitive hydrogel. The preparation method of the nasal temperature-sensitive hydrogel with the immunoregulation and anti-inflammatory functions comprises the following steps: preparation of hydroxybutyl chitosan (HBC), preparation of levodopa-hydroxybutyl chitosan (LHBC), and preparation of CELHBC composite hydrogel. The novel temperature-sensitive hydrogel composite material of the composite hydrogel loaded with the chlorella / exosome can be used for the focus position of allergic rhinitis, and enrichment and retention of active ingredients are achieved; the chlorella is combined with the exosome, so that the inflammatory response of nasal mucosa can be relieved, the damaged nasal mucosa can be repaired, and the immune imbalance of Th1 / Th2 cells can be reversed, thereby improving the treatment effect of allergic rhinitis.
Owner:OCEAN UNIV OF CHINA

Traditional Chinese medicine preparation for treating allergic rhinitis and preparation method thereof

The invention provides a traditional Chinese medicine preparation for treating allergic rhinitis and a preparation method thereof, and relates to the technical field of traditional Chinese medicine pharmacy, the traditional Chinese medicine preparation is prepared from radix asteris, schizonepeta spike, cynanchum paniculatum, perillaseed, spina gleditsiae, cottonrose hibiscus leaf, magnolia flower, semen brassicae, cortex lycii radicis, dendrobe, oroxylum indicum and rhodomyrtus tomentosa; an in-vitro experiment shows that the traditional Chinese medicine preparation can remarkably inhibit the activity of hyaluronidase, also can inhibit the release of beta-HEX in an RBL-2H3 cell degranulation model, reduces the HIS level in a cell supernatant, and effectively improves the morphological abnormality caused by degranulation of RBL-2H3 cells; in-vivo experiments show that the traditional Chinese medicine preparation can significantly reduce behavioral scores of mice suffering from allergic rhinitis, inhibit expression of inflammatory factors TNF-alpha, serum Ig E and OVE-sIg E levels and HA concentration, reduce histopathologic changes caused by allergic rhinitis, effectively repair immune injuries of nasal mucosa of the mice and improve the curative effect of the mice. And a safe and effective new strategy is provided for the treatment of allergic rhinitis.
Owner:HENAN UNIV OF CHINESE MEDICINE

Application of APE1 inhibitor in preparation of medicine for treating allergic rhinitis

The invention belongs to the field of compound medicines, and relates to application of an APE1 inhibitor in preparation of a medicine for treating allergic rhinitis. The invention finds that the APE1 inhibitor can effectively relieve and treat the allergic rhinitis for the first time, a new target and a new way are provided for prevention and treatment of the allergic rhinitis, and the APE1 inhibitor C10 compound and a small molecule compound represented by the APE1 inhibitor C10 compound show an excellent effect in treatment of the allergic rhinitis.
Owner:SHANDONG UNIV QILU HOSPITAL

Manganese-based Prussian blue-polyacrylic acid / polyvinyl alcohol hydrogel for preventing and treating allergic rhinitis

The invention discloses manganese-based Prussian blue-polyacrylic acid / polyvinyl alcohol hydrogel for preventing and treating allergic rhinitis. Monodisperse manganese-based Prussian blue nanoparticles synthesized by taking polyacrylic acid as a template are stably immobilized in a polyacrylic acid / polyvinyl alcohol hydrogel matrix. The obtained composite hydrogel membrane has the following prominent advantages: the composite hydrogel membrane has excellent hydrogel characteristics, including controllable membrane thickness, good tissue adhesion and air permeability; reliable biocompatibility and safety are shown; allergen permeation is effectively blocked through a physical barrier effect; prussian blue is continuously released in the slow-release degradation process, active oxygen free radicals are remarkably removed, and the powerful anti-inflammatory effect is achieved. Due to the synergistic effect of double mechanisms of protection and treatment, the material has important clinical application value and development potential in the fields of prevention and treatment of allergic rhinitis.
Owner:NORTHEAST NORMAL UNIVERSITY

Pediococcus pentosaceus CQFP202426 and application thereof in preparation of medicine for preventing or treating allergic rhinitis

The invention provides pediococcus pentosaceus CQFP202426 and application of the pediococcus pentosaceus CQFP202426 in preparation of drugs for preventing or treating allergic rhinitis, and belongs to the technical field of microorganisms. The pediococcus pentosaceus CQFP202426 provided by the invention has a preservation number of CGMCC (China General Microbiological Culture Collection Center) No.29782, is preserved in the China General Microbiological Culture Collection Center on January 26, 2024, and is preserved in Institute of Microbiology, Chinese Academy of Sciences, No.3, No.1 Yard, West Beichen Road, Chaoyang District, Beijing. The strain can relieve oxidative stress injury, inhibit inflammatory response and regulate immune balance, and has a remarkable effect on prevention and treatment of allergic rhinitis.
Owner:CHONGQING UNIV OF EDUCATION

Traditional Chinese medicine composition for treating allergic rhinitis as well as preparation method and application of traditional Chinese medicine composition

The invention discloses a traditional Chinese medicine composition for treating allergic rhinitis, which is prepared from the following raw materials in parts by weight: 6 to 30 parts of folium mori, 6 to 30 parts of flos chrysanthemi, 1 to 9 parts of radix ginseng, 10 to 30 parts of fructus ziziphi jujubae, 3 to 10 parts of rhizoma zingiberis recens, 3 to 10 parts of liquorice root, 10 to 30 parts of radix astragali seu hedysari, 3 to 12 parts of radix angelicae sinensis, 6 to 15 parts of radix ophiopogonis, 1 to 6 parts of radix puerariae, 3 to 12 parts of radix angelicae dahuricae, 3 to 9 parts of herba menthae and 3 to 10 parts of radix platycodonis. The preparation method of the traditional Chinese medicine composition comprises the following steps: (1) respectively taking the raw materials in parts by weight, and adding water to soak for 1 hour; step 2) adding water and decocting twice, adding 400-900 parts by volume of water each time, boiling and decocting with strong fire for the first time, adding water and boiling with slow fire for the second time, and combining decoctions; and (3) adding pharmaceutically acceptable medicinal auxiliary agents according to a conventional process to prepare clinically acceptable granules, pills, tablets, powder or capsules. The traditional Chinese medicine composition has the effects of resisting allergy, inflammation and bacteria and the like, and can relieve the symptoms of nasal obstruction, running nose, sneezing and the like of allergic rhinitis patients.
Owner:王进福

Application of bifidobacterium longum subsp. Infantis in prevention and / or treatment of allergic rhinitis

The invention relates to the technical field of biological medicines, in particular to application of bifidobacterium longum subsp. Infantis in prevention and / or treatment of allergic rhinitis. Researches find that the Bifidobacterium longum subsp.infantis can improve inflammatory response, relieve symptoms of allergic rhinitis of mice, inhibit immune response caused by the allergic rhinitis, inhibit the inflammatory response caused by the allergic rhinitis and / or repair nasal mucosa injury caused by the allergic rhinitis, and the Bifidobacterium longum subsp.infantis can be used for treating the allergic rhinitis. The compound has a huge application prospect in preparation of products for preventing and / or treating allergic rhinitis.
Owner:SHENZHEN XBIOME BIOTECH CO LTD

Improved nasal administration of pharmaceutical formulations

Disclosed herein are methods of treating allergic rhinitis, nasal polyp, and / or nasosinusitis in a subject comprising intranasally administering a corticosteroid, an ester thereof, or a salt thereof to the subject via a nasal spray device. Also disclosed herein are devices and kits for administering a corticosteroid, ester, or salt thereof to a subject in need thereof. The nasal spray devices herein deliver dosage units that can be used to treat diseases disclosed herein.
Owner:SERINO MEDICAL CO LTD

Lactobacillus reuteri for improving allergic rhinitis and nasosinusitis as well as product and application of lactobacillus reuteri

The invention relates to the technical field of microorganisms, in particular to lactobacillus reuteri for improving allergic rhinitis and nasosinusitis as well as a product and application thereof. The lactobacillus reuteri NHNK-2001 disclosed by the invention is deposited in the China Center for Type Culture Collection, and the preservation number is CCTCC NO: M 2024800. Experiments show that the NHNK-2001 has the functions of inhibiting the growth of nasosinusitis related flora and biofilm formation, flocculating rhinitis pathogenic bacteria, promoting the growth of nasal cavity beneficial bacteria, inhibiting staphylococcus aureus subsp.aureus enterotoxin, degrading histamine, reducing histamine excitation, promoting nasal cavity epithelial cell barrier and reducing nasal cavity epithelial cell inflammation; in addition, a biological membrane formed by the NHNK-2001 thallus can increase the colonization ability to intestinal epithelial cells. The traditional Chinese medicine composition can be used for preparing products for improving allergic rhinitis and nasosinusitis.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD

Single traditional Chinese medicine powder spray for radically treating allergic rhinitis as well as preparation and application of single traditional Chinese medicine powder spray

The invention discloses a single traditional Chinese medicine powder spray for radically treating allergic rhinitis and preparation and application thereof.The single traditional Chinese medicine powder spray only contains gleditsia sinensis powder, is simple in composition and can temporarily stimulate epithelial cells to secrete normal nasal discharge to block and flush allergens, and nasal cavity flushing is achieved; the traditional Chinese medicine composition can change the local microenvironment of nasal mucosa and cut off the biological process of occurrence and development of allergic rhinitis, and enters the nasal mucosa to serve as a descaling agent, so that an IgE receptor Fc epsilon R1 on a sensitized mast cell membrane is separated from IgE and cannot be combined with allergens, and the mast cell cannot activate and release an allergic medium, so that the allergic rhinitis is radically treated; the preparation process of the single traditional Chinese medicine powder spray is simple and easy to operate, batch production can be realized, and after the saponin powder is processed by the alum, the astringency effect is remarkable, so that the clear water snot symptom of the allergic rhinitis can be improved; the nasal spray is used for treating allergic rhinitis, stimulates secretion of nasal discharge after being sprayed, and is beneficial to cleaning nasal cavities and improving nasal ventilation; the traditional Chinese medicine composition also has a sterilization function and can effectively inhibit bacterial and fungal infection induced by allergic rhinitis.
Owner:XI AN JIAOTONG UNIV

Application of volatile oil from citrus aurantium in preparation of medicine for preventing and treating allergic rhinitis

The application discloses application of volatile oil of Citrus aurantium in preparation of a medicine for preventing and treating allergic rhinitis. The application proposes that the volatile oil of Citrus aurantium can significantly reduce the levels of mast cell factors IL-1beta and TNF-alpha, and can also significantly reduce the levels of inflammatory factors IL-13 and IL-4 in mice, reduce inflammatory cell infiltration, and reduce eosinophilic granulocyte increase and gland hyperplasia. The application proposes that the volatile oil of Citrus aurantium has great potential as a medicinal and edible raw material for treating allergic rhinitis. The application also proposes that the volatile oil of Citrus aurantium can significantly improve symptoms such as sneezing, runny nose, and nasal itching of mice caused by allergic rhinitis, and the symptoms seriously affect the life of patients.
Owner:SUN YAT SEN UNIV

Application of plant lactobacillus in preparation of preparation for preventing and / or treating allergic rhinitis

The invention relates to application of plant lactobacillus in preparation of a preparation for preventing and / or treating allergic rhinitis. The plant lactobacillus comprises Lactobacillus plantarum BGI-N6, the Lactobacillus plantarum BGI-N6 is preserved in the China Center for Type Culture Collection on June 5, 2023, and the preservation number of the Lactobacillus plantarum BGI-N6 is CCTCC (China Center for Type Culture Collection) NO: M2023948. Based on an allergic rhinitis animal model, the action mechanism of the plant lactobacillus in the inflammation process is deeply analyzed, it is found that the plant lactobacillus can effectively prevent and / or treat the allergic rhinitis, and a new strategy is provided for developing a scheme for treating the allergic rhinitis.
Owner:BGI PRECISION NUTRITION (SHENZHEN) TECHNOLOGY CO LTD